Search research articles
Contact Us
Filters
Showing results (121-130 of 280) with videos related to
Page
of 28
Sort By:
Metabolism: Clinical and Experimental
|
August 11, 2019
The metabolic regulator small heterodimer partner contributes to the glucose and lipid homeostasis abnormalities induced by hepatitis C virus infection
Jizheng Chen, Yue Zhou, Yuan Zhuang, et al.
Cellular & Molecular Immunology
|
December 23, 2014
Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients
Naicui Zhai, Xiumei Chi, Tianyang Li, et al.
Plos One
|
January 24, 2017
Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling
Naicui Zhai, Haijun Li, Hongxiao Song, et al.
Clinical Therapeutics
|
September 7, 2018
Pharmacokinetics, Safety, and Tolerability of the Direct-acting Hepatitis C Antiviral Sofosbuvir in HealthyChineseSubjects
Xiaojiao Li, Hong Chen, Junqi Niu, et al.
Frontiers in Pharmacology
|
November 2, 2020
A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects
Hong Zhang, Min Wu, Xiaoxue Zhu, et al.
Alimentary Pharmacology & Therapeutics
|
November 29, 2020
Randomised clinical trial: safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection
Hong Zhang, Yue Hu, Min Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 6, 2021
A randomized dose-escalation study on the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of a novel recombinant human albumin in healthy subjects
Cuiyun Li, Wei Xiang, Min Wu, et al.
Mbio
|
May 19, 2022
Dual-Role of Cholesterol-25-Hydroxylase in Regulating Hepatitis B Virus Infection and Replication
Qi Wei, Hongxiao Song, Yanli Gao, et al.
Expert Opinion on Investigational Drugs
|
January 6, 2021
Safety, pharmacokinetics and pharmacodynamics of TQ-A3334, an oral toll-like receptor 7 agonist in healthy individuals
Yue Hu, Hong Zhang, Min Wu, et al.
Experimental and Therapeutic Medicine
|
April 29, 2017
Changes in liver stiffness and its associated factors during oral antiviral therapy in Chinese patients with chronic hepatitis B
Xu Li, Qinglong Jin, Hong Zhang, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 280) with videos related to
Sort By:
Page
of 28
Metabolism: Clinical and Experimental
|
August 11, 2019
The metabolic regulator small heterodimer partner contributes to the glucose and lipid homeostasis abnormalities induced by hepatitis C virus infection
Jizheng Chen, Yue Zhou, Yuan Zhuang, et al.
Cellular & Molecular Immunology
|
December 23, 2014
Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients
Naicui Zhai, Xiumei Chi, Tianyang Li, et al.
Plos One
|
January 24, 2017
Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling
Naicui Zhai, Haijun Li, Hongxiao Song, et al.
Clinical Therapeutics
|
September 7, 2018
Pharmacokinetics, Safety, and Tolerability of the Direct-acting Hepatitis C Antiviral Sofosbuvir in HealthyChineseSubjects
Xiaojiao Li, Hong Chen, Junqi Niu, et al.
Frontiers in Pharmacology
|
November 2, 2020
A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects
Hong Zhang, Min Wu, Xiaoxue Zhu, et al.
Alimentary Pharmacology & Therapeutics
|
November 29, 2020
Randomised clinical trial: safety, efficacy and pharmacokinetics of HS-10234 versus tenofovir for the treatment of chronic hepatitis B infection
Hong Zhang, Yue Hu, Min Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 6, 2021
A randomized dose-escalation study on the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of a novel recombinant human albumin in healthy subjects
Cuiyun Li, Wei Xiang, Min Wu, et al.
Mbio
|
May 19, 2022
Dual-Role of Cholesterol-25-Hydroxylase in Regulating Hepatitis B Virus Infection and Replication
Qi Wei, Hongxiao Song, Yanli Gao, et al.
Expert Opinion on Investigational Drugs
|
January 6, 2021
Safety, pharmacokinetics and pharmacodynamics of TQ-A3334, an oral toll-like receptor 7 agonist in healthy individuals
Yue Hu, Hong Zhang, Min Wu, et al.
Experimental and Therapeutic Medicine
|
April 29, 2017
Changes in liver stiffness and its associated factors during oral antiviral therapy in Chinese patients with chronic hepatitis B
Xu Li, Qinglong Jin, Hong Zhang, et al.
Page
of 28